Cameroon vs Zimbabwe: Treatment coverage for schistosomiasis
Cameroon
56.3%
in 2024
Zimbabwe
53.7%
in 2024
Cameroon rank
15th
Zimbabwe rank
17th
Treatment coverage for schistosomiasis over time
- Cameroon
- Zimbabwe
How they compare
Cameroon currently reports 56.3% against 53.7% in Zimbabwe, a difference of 2.6%.
The two have swapped places 5 times across 9 shared years of data; in 2012 it was Zimbabwe ahead.
Cameroon ranks 15th and Zimbabwe ranks 17th of 45 countries.
Across the 2 decades both report, Cameroon averaged higher in 1 and Zimbabwe in 1.
Head to head by decade
| Decade | Cameroon | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 42.1% | 51.7% | 9.7% | Zimbabwe |
| 2020s | 54.8% | 38.7% | 16.1% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Cameroon or Zimbabwe?
- Cameroon, at 56.3% against 53.7% in Zimbabwe as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Cameroon and Zimbabwe?
- 2.6%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Zimbabwe?
- 9 years are reported by both, from 2012 to 2024.
- How do Cameroon and Zimbabwe rank globally for treatment coverage for schistosomiasis?
- Cameroon ranks 15th and Zimbabwe ranks 17th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.